Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG

Professor

Pharmacy Clinical & Admin Sci

Phone (405) 271-6878 x47296

Office O'Donoghue Research Bldg., 1122 NE 13th St., Ste. 4417, OKC 73117

Email jamie-miller@ouhsc.edu


Publications & Presentations

1 2 3 4 > >>
    1. Flanagan T, Mercer K, Johnson P N, Miller J L, Perrine J. Ketamine Use in Adult and Pediatric Patients Receiving Extracorporeal Membrane Oxygenation (ECMO): A Systematic Review. Journal of Pharmacy Practice. 2023

    2. Johnson P N, Parman A, Miller J L. Training the next generation of peer reviewers: Steps for guiding pharmacy learners through the peer review process. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2023

    3. Rathbun C, Lewis M M, Yuet W C, Woo S, Miller J L, Skrepnek G H. The Medication Possession Ratio as a Predictor of Longitudinal HIV-1 Viral Suppression. The Annals of pharmacotherapy. 2023; 57 : 1264-1272

    4. Casten M, Miller J L, Neely S, Harkin M, Johnson P N. Variability in opioid conversion calculators in critically ill children transitioned from fentanyl to hydromorphone. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2023

    5. Zelnicek T, Siegrist E A, Miller J L, Neely S, White B P. Comparison of dosing strategies in obese patients prescribed intravenous acyclovir and evaluation of rate of acute kidney injury. International journal of antimicrobial agents. 2023; 62 : 106871

1 2 3 4 > >>



Grants

    1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.

    2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

    3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

    4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

    5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.




Awards and Honors

1 2 >>
                                                                                            1. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.  

                                                                                            2. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.  

                                                                                            3. Pediatric Pharmacy Association. Christensen Memorial Young Investigator Award Nominee (Resident Mentor). Date: 2022.  

                                                                                            4. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2019.  

                                                                                            5. University of Oklahoma College of Pharmacy; Department of Clinical and Administrative Sciences. Best Paper Award. Date: 2018.  

1 2 >>



Education

                                                                                            1.  Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.  

                                                                                            2.  Degree: BS. Trevecca Nazarene University. Date: 2002.